| 566.10 Data as of Jun 03 | Today’s Change | 0.00 |||52-Week Range 4,000.00 | -0.70% Year-to-Date |
| Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner May 17 / TheStreet.com | Dirty Medicine May 15 / Fortune |
| Analysts' Actions: AMAT ARUN BMY DE WSM May 17 / TheStreet.com | Amgen to Set Up JV in China - Analyst Blog May 14 / Zacks.com |
| 5 Stock Trades for S&P 1,700 May 16 / TheStreet.com | Simcere Beats 1Q Earnings & Revenue Estimate - Analyst Blog May 10 / Zacks.com |
| ASCO '13 Preview: New 'Anti-PD-1' Therapies Shrink Tumors May 15 / TheStreet.com | Good News for Bristol-Myers - Analyst Blog May 06 / Zacks.com |
| Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog May 15 / Zacks.com | Narrower-than-Expected Loss at Cadence - Analyst Blog May 06 / Zacks.com |
| India: Patents and precedents May 15 / FT.com | Letter from Lex: Big numbers May 03 / FT.com |
| 5 Stocks Boosting The Drugs Industry Higher May 15 / TheStreet.com | Investors: Look beyond Merck's patent loss May 01 / Money |
| Bristol-Myers Squibb Reaches New 52-Week High (BMY) May 15 / TheStreet.com | US pharma: spot the difference Apr 29 / FT.com |